Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Apr 22, 2026
drug shortage
Morphine Sulfate Injection shortage — Hospira, Inc., a Pfizer Company
Teva Pharmaceuticals USA Inc
→
Apr 22, 2026
drug shortage
Fentanyl Citrate Injection shortage — Hospira, Inc., a Pfizer Company
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Azacitidine Injection shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Hydromorphone Hydrochloride Injection shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Methylphenidate Hydrochloride Tablet, Extended Release shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Lisdexamfetamine Dimesylate Capsule shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Methotrexate Sodium Injection shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Hydroxocobalamin Injection shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Clonazepam Tablet shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 16, 2026
drug shortage
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 15, 2026
drug shortage
Tiagabine Hydrochloride Tablet shortage — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA Inc
→
Apr 6, 2026
approval
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approval
DAPAGLIFLOZIN
→
Apr 6, 2026
approval
DAPAGLIFLOZIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 18, 2026
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 18, 2026
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 12, 2026
approval
POMALIDOMIDE — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 11, 2026
approval
FERRIC CITRATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 27, 2026
device 510k
Avita Corporation — AViTA Pulse Oximeter (SP61) (510k cleared)
Teva Pharmaceuticals USA Inc
→
Feb 10, 2026
approval
SULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 10, 2026
approval
FLUOROURACIL — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 10, 2026
approval
FLUOROURACIL — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 9, 2026
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 9, 2026
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 26, 2026
approval
FINASTERIDE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 25, 2026
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 25, 2026
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 25, 2026
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 25, 2026
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 25, 2026
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 25, 2026
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→